Can this covid-times saviour navigate the self-inflicted deep slump?
The all-or-nothing strategy has landed the ‘pride of the pharmaceutical industry' in a situation that deteriorated rapidly.
Activist Starboard Trailed Peers With Less Than 5% Returns
Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large ...